-
公开(公告)号:KR101962373B1
公开(公告)日:2019-03-26
申请号:KR1020170006198
申请日:2017-01-13
Applicant: 포항공과대학교 산학협력단 , 가톨릭대학교 산학협력단
-
公开(公告)号:KR1020110087674A
公开(公告)日:2011-08-03
申请号:KR1020100007205
申请日:2010-01-27
Applicant: 가톨릭대학교 산학협력단
Abstract: PURPOSE: An ex vivo method for proliferating endothelial progenitor cells(EPCs) is provided to effectively proliferate EPCs and prevent or treat anginogenesis and ischemic diseases. CONSTITUTION: A method for proliferating EPCs comprises a step of culturing CD34+ cel fraction in a serum-free medium containing SCF(stem cell factor), FLT-3L(FLT-3 ligand), IL-3, and bFGF(basic fibroblast growth factor). The culture is a non-adhesive ex vivo culture. The EPCs are derived from bone marrow, peripheral blood, or umbilical cord blood.
Abstract translation: 目的:提供增强内皮祖细胞(EPCs)的离体方法,有效增殖EPCs,预防或治疗血管发生和缺血性疾病。 构成:增殖EPCs的方法包括在含有SCF(干细胞因子),FLT-3L(FLT-3配体),IL-3和bFGF(碱性成纤维细胞生长因子)的无血清培养基中培养CD34 +细胞级分的步骤 )。 培养物是一种非粘性离体培养物。 EPCs来源于骨髓,外周血或脐带血。
-
公开(公告)号:KR101132858B1
公开(公告)日:2012-04-03
申请号:KR1020100007205
申请日:2010-01-27
Applicant: 가톨릭대학교 산학협력단
Abstract: PURPOSE: An ex vivo method for proliferating endothelial progenitor cells(EPCs) is provided to effectively proliferate EPCs and prevent or treat anginogenesis and ischemic diseases. CONSTITUTION: A method for proliferating EPCs comprises a step of culturing CD34+ cel fraction in a serum-free medium containing SCF(stem cell factor), FLT-3L(FLT-3 ligand), IL-3, and bFGF(basic fibroblast growth factor). The culture is a non-adhesive ex vivo culture. The EPCs are derived from bone marrow, peripheral blood, or umbilical cord blood.
-
-